Steven Hite Appointed Chief Operating Officer of Thrombotargets Corporation

Published: Jun 14, 2007

Durham, NC, June 1, 2007 – Thrombotargets Corp., a privately held group of Biotech Company focused in the discovery and development of innovative drugs, is pleased to announce the appointment of Steve A. Hite to Chief Executive Officer. Reporting to the Executive Vice President, Dr. Caveda, Mr. Hite will be responsible for Business Development Strategy, corporate development, the development and enforcement of corporate policies and procedures, and government affairs.

Back to news